(25 Oct 2024, 18:53)

Cipla completes acquisition of additional 6.9% stake in Cipla Jiangsu

Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cipla announced that Cipla (EU), wholly owned subsidiary of the Company in UK has completed all the conditions with respect to acquisition of 6.9124% equity interest in Cipla (Jiangsu) Pharmaceuticals Co., China (Cipla Jiangsu) on 25 October 2024. Cipla Jiangsu is now a wholly owned step-down subsidiary of the Company.

More News

(06-Nov-2024 09:11)
Polycab India emerges lowest bidder for Rs 4099 cr BSNL project
(06-Nov-2024 09:28)
SEAMEC update on deployment of its vessel “SEAMEC PRINCESS"
(06-Nov-2024 09:53)
Espire Hospitality to discuss results
(06-Nov-2024 09:53)
Concord Biotech to conduct board meeting

More Company News View Company Information

Hot Pursuit (04-Nov-2024 13:05)
Cipla Ltd soars 1.44%, Gains for third straight session
Hot Pursuit (31-Oct-2024 10:59)
Cipla spurts after USFDA classifies Goa unit as VAI
Hot Pursuit (29-Oct-2024 15:18)
Cipla Q2 PAT rises 15% YoY to Rs 1,303 cr
Results - Announcements (29-Oct-2024 15:32)
Cipla consolidated net profit rises 15.18% in the September 2024 quarter
Corporate News (25-Oct-2024 18:53)
Cipla completes acquisition of additional 6.9% stake in Cipla Jiangsu
Hot Pursuit (21-Oct-2024 13:35)
Cipla Ltd slips for fifth straight session
Hot Pursuit (09-Oct-2024 13:05)
Cipla Ltd gains for third straight session

Corporate News

Cipla completes acquisition of additional 6.9% stake in Cipla Jiangsu